medigraphic.com
ISSN 2007-3194 (Print)
Órgano de difusión oficial del Instituto Materno Infantil del Estado de México

2012, Number 3

<< Back Next >>

Arch Inv Mat Inf 2012; 4 (3)

Morbimortalidad del recién nacido hijo de madre en estado crítico

Pineda ML, Suárez DMS, Pardo MRV

Language: Spanish
References: 26
Page: 131-138
PDF size: 102.56 Kb.


ABSTRACT

Introduction: The health of mothers is a determinant in the health of children neonatal morbidity and mortality depend on the quality of care they received during their pregnancies, including maternal diseases are preeclampsia, obstetric hemorrhage, heart disease, maternal gestational diabetes and so on. Having complications due to various organ systems of the newborn. Objective: Determine morbidity and mortality of the newborn child of a mother in critical condition in the intensive care unit of the Hospital of Gynecology and Obstetrics IMIEM, gender, weight, Apgar score, weeks of gestation, number of exploits, breast pathology, services that were entered, organ system complications, length of stay and cause of discharge. Material and methods: Data were collected on the sheet previously designed for the study and responses were coded for the production database for subsequent statistical analysis software SPSS for Windows version 17. Descriptive statistics were obtained; the results are presented in tables and graphs. Results: The total population of the study was 231 newborns critically ill mothers, of whom 138 were healthy newborns, and 93 were patients, female gender was more prevalent in 51.9%, the path of birth was a cesarean section 84.8%, the most common-minute Apgar score was 7-10, the most frequent maternal pathology preeclampsia 79.6%, the most common respiratory disease was 20.3 hyaline membrane disease with application of exogenous surfactant, the length of stay were 1-224 were discharged six days for improvement and seven patients for death that is 3%. Conclusions: As the world literature of pathology that affects mothers is preeclampsia, and major complications in these mothers were hyaline membrane disease and intrauterine growth restriction, we saw a patient preterm generates more costs and more days hospital stay, hyaline membrane disease warrants application of exogenous surfactant, the sooner was the discharge prognosis was better, stay longer generated more sequels.


REFERENCES

  1. La Neonatología y el Recién Nacido en el marco de los objetivos del milenio de la Organización Mundial de la Salud, Noviembre 2010 [Internet]. Disponible en: http://www.doxamedica.com/index.php?option=com_myblog&show=la-neonatologa-a-y-el-recia-n-nacido-en-el-marco-de-los-objetivos-del-milenio-de-la-organizacia-n-mundial-de-la-saludhtml&Itemid=193

  2. Arias F. Guía práctica para el embarazo y el parto de alto riesgo. 2ª ed. Madrid, España: Mosby/Doyma, 1994.

  3. Duckitt K. Risk factors for preeclampsia at antenatal booking: systematic review of controlled studies. BMJ, 2005; 300: 565.

  4. Peralta PML, Guzmán IMA, Cruz AA, Martínez GMC. Utilidad para establecer el diagnóstico y severidad de los síntomas y signos más frecuentes de la paciente preeclámptica. Gac Med Mex, 2004; 140: 513-517.

  5. Sibai MB. Hypertensive, disorders of pregnancy: the United States perspective. Curr Opin Obstet Gynecol, 2008; 20: 102-106.

  6. Benavides-Serralde JA, Guzmán-Huerta ME, Hernández-Andrade de E. Restricción del crecimiento intrauterino por insuficiencia placentaria, diagnóstico y manejo. En: Guzmán HME Editor. Avances en Medicina y Cirugía Fetal. Clínicas de Perinatología y Reproducción Humana. México: Elservier, 2009: 1-17.

  7. Romo A, Carceller R, Tobajas J. Intrauterine growth retardation (IUGR): epidemiology and etiology. Pediatr, Endocrinol Rev, 2009; 6: 332-336.

  8. Gómez-Gómez M. Fetopatía toxémica. En: Gómez-Gómez M, editor. Temas selectos sobre el recién nacido prematuro. México: Distribuidora y Editora Mexicana, 1990: 104-109.

  9. Gómez-Gómez M, Danglot-Banck C. El neonato de madre con preeclampsia-eclampsia. Rev Mex de Pediatr, 2006; 73 (2): 82-88.

  10. Romero-Maldonado S, Blaz-Rodríguez U, Asencio-Mujica M, Villalobos-Alcázar G, López-Barrera MD. Riesgo de morbilidad en el hijo de madre con enfermedad hipertensiva inducida por el embarazo. Estudio de cohorte comparativa. Perinatol Reprod Hum, 2003; 17: 133-145.

  11. Veloz-Martínez MG, Martínez-Rodríguez OA, Ahumada-Ramírez E, Puello-Tamara ER, Amezcua-Galindo FJ, Hernández-Valencia M. Eclampsia, hemorragia obstétrica y cardiopatía como causa de mortalidad materna en 15 años de análisis. Ginecol Obstet Mex, 2010; 78 (4): 215-218.

  12. Gordon B Avery, Mhairi G MacDonald, Mary MK Seshia, Martha D Muilet. Avery’s neonatology: Pathophysioloy & management of the newborn. 6th edition. Edit Lippincott, 2005: 1172.

  13. Leitner Y, Fattal-Valevsky A, Geva R, Esherl R, Toledano-Alhadef H, Rotstein M et al. Neurodevelopmental outcome of children with intrauterine growth retardation: a longitudinal 10-year prospective study. J Child Neurol, 2007; 22: 580-587.

  14. Coustan DR. Diabetes in pregnancy. In: Fanaroff AA, Martin RJ. Neonatal, perinatal Medicine. Diseases of the fetus an infant. 6th Ed St Luis, Mosby, 2007: 258-263.

  15. Kapoor N, Sankaran S, Hyer S, Schehata H. Diabetes in pregnancy: a review of current evidence. Curr Opin Obstet Gynecol, 2007; 19: 586-590.

  16. Hernández-Andrade E, Gerulewicz VD, Sola A. Patologías maternas y su efecto en la vida del feto y el recién nacido. En: Sola A. Cuidados Neonatales, descubriendo la vida de un recién nacido enfermo. Tomo I. Buenos Aires: Edimed-Ediciones Médicas SRL, 2011: 11-22. 17. Jones CW. Gestational diabetes and its impact on the neonate. Neonatal New, 2001; 20: 17-23.

  17. Lee-Parritz A, Cloherty JP. Diabetes mellitus. En: Cloherty JP. Manual de cuidados neonatales. 4ª ed. Barcelona: Masson, 2005: 11-22.

  18. Gomella TL. Infant of a diabetic mother. In: Gomella TL, Conningham MD, Eyal FG, editors. Neonatology: a Lange Clinical manual. 6th ed. New Jersey: Prentice-Hall International, 2009: 534-540.

  19. Alam M, Raza JS, Sherali AR, Akhtar SM. Neonatal complications in infants born to diabetic mothers. J Coll Physicians Surg Pak, 2006; 16: 212-215.

  20. Hernández GA, Rey BJR, Martí AC. Enfermedades cardiacas y gestación. En: Cabero RL, Saldivar RD, Cabrillo RE. Obstetricia y medicina materno-fetal. Madrid, España: Ed. Médica Panamericana, 2007: 797-804.

  21. Sola A. Diálogos en Neonatología: aprendiendo de las preguntas. Buenos Aires: Edimed Ediciones Médicas SRL, 2001.

  22. Fischer R. Thrombocytopenia in pregnancy [Cited: June 26, 2011]. Available in: http//:www.emedicine.com/med/topic3480/html

  23. Martínez-Contreras AM, Soria-Rodríguez CG, Prince-Vélez R, Clark-Ordoñez I, Medina-Ramírez MCR. Preeclampsia: principal factor de riesgo materno para bajo peso del recién nacido pretérmino. Ginecol Obstet Mex, 2008; 76 (7): 398-403.

  24. Portal SY, Campos CA, Portal MME, Breto RAG, Menéndez HYR. Morbilidad y mortalidad en neonatos hijos de madres toxémicas. Revista Cubana de Pediatría, 2009 [Internet]. Disponible en: http://scielo.sld.cu/pdf/ped/v81n3/ped05309.pdf

  25. Martínez J et al. Influencia del tipo de estado hipertensivo del embarazo en la aparición de complicaciones neonatales. Rev Esp Pediatría, 1998; 54 (5): 379-385.

  26. Jordán-García I, Quintana-Martínez JM, Alcover EB, González LG, Rodríguez-Miguélez JM, Figueras AJ. Morbilidad del recién nacido hijo de madre diabética con relación a macrosomía. Ann Esp Pediatr, 1999; 50: 275-278.




2020     |     www.medigraphic.com